In the second episode of The Lung Lab, Dr. Lisa Lancaster – director of the Interstitial Lung Disease (ILD) program at Vanderbilt University and chief medical officer at Endeavor Biometrics – discusses the long and winding road many lung disease patients often face on their way to diagnosis.

A pulmonologist with over 25 years of experience and 85 clinical trials behind her, Dr. Lancaster is one of the most respected voices in the ILD space. She shares her perspective on the emotional challenges of delivering life-changing news, the promise of emerging therapies, and the future of ILD treatment she hopes to see.